A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patients in the United States

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The aim of this study was to characterize real-world treatment patterns, including therapy sequences, escalation, and duration, and treatment outcomes in IgA nephropathy (IgAN) patients in the United States (US). The study used data which has detailed information on renal biopsy and laboratory data, linked with medical and pharmacy claims.
Epistemonikos ID: d44296aacb8e701ddd0a79b457aab6225c0b9d3b
First added on: Aug 12, 2026